Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2025-12-25 @ 7:03 PM
Study NCT ID:
NCT06394804
Status:
RECRUITING
Last Update Posted:
2025-07-29
First Post:
2024-04-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-29
First Submit QC Date:
None
Study First Post Date:
2024-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-28
Last Update Post Date:
2025-07-29
Last Update Post Date Type:
ACTUAL